MTOR and diabetic cardiomyopathy: In diabetic cardiomyopathy, upregulation of the mammalian target of rapamycin (mTOR) pathway accelerates pyroptosis, resulting in myocardial hypertrophy and collagen deposition, which further exacerbate cardiac dysfunction [63].